TENAX THERAPEUTICS, INC. 10-K Cybersecurity GRC - 2024-03-28

Page last updated on April 11, 2024

TENAX THERAPEUTICS, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-28 14:02:07 EDT.

Filings

10-K filed on 2024-03-28

TENAX THERAPEUTICS, INC. filed an 10-K at 2024-03-28 14:02:07 EDT
Accession Number: 0001654954-24-003827

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C CYBERSECURITY The Company has a cybersecurity strategy designed to protect our information systems and data from an evolving cyber-threat landscape. Our cybersecurity program, administered by the Company s Senior Network Administrator and overseen by the Audit and Compliance Committee, has the support of executive leadership and the Board of Directors, and the Company continues to invest in cybersecurity to protect the Company s systems. Our cybersecurity program focuses on all areas of our business, including cloud-based environments, devices used by employees and contractors, facilities, networks, applications, vendors, disaster recovery, business continuity and controls and safeguards enabled through business processes and tools. We continuously monitor for threats and unauthorized access. We learn of security threats through automated detection solutions as well as reports from users and business partners. We draw on the knowledge and insight of external cybersecurity experts and vendors and employ an array of third-party tools to secure our information infrastructure and protect systems and information from unauthorized access. As of the date of this Annual Report, we have not encountered any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect the Company, including its business strategy, results of operations, or financial condition. For more information on our cybersecurity related risks, see Risk Factors - Risks Related to Our Industry included elsewhere in this Annual Report on Form 10-K.


Company Information

NameTENAX THERAPEUTICS, INC.
CIK0000034956
SIC DescriptionPharmaceutical Preparations
TickerTENX - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30